Koers Alexion Pharmaceuticals, Inc.
Aandelen
ALXN
US0153511094
Farmaceutische producten
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Marc Dunoyer
CEO | Chief Executive Officer | 71 | - |
Sean Christie
DFI | Director of Finance/CFO | - | 01-08-21 |
Chief Tech/Sci/R&D Officer | - | 01-12-20 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+24,75% | 556 mld. | |
-6,33% | 354 mld. | |
+19,90% | 331 mld. | |
+7,95% | 296 mld. | |
+13,40% | 233 mld. | |
+5,50% | 201 mld. | |
-10,18% | 193 mld. | |
-12,26% | 143 mld. | |
-6,47% | 144 mld. |